162 related articles for article (PubMed ID: 24385304)
21. XPC Polymorphism Increases Risk of Digestive System Cancers: Current Evidence from A Meta-Analysis.
Jiang X; Zhou LT; Zhang SC; Chen K
Chin J Cancer Res; 2012 Sep; 24(3):181-9. PubMed ID: 23359774
[TBL] [Abstract][Full Text] [Related]
22. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms.
Zhu Y; Yang H; Chen Q; Lin J; Grossman HB; Dinney CP; Wu X; Gu J
DNA Repair (Amst); 2008 Feb; 7(2):141-8. PubMed ID: 17923445
[TBL] [Abstract][Full Text] [Related]
23. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
24. [A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma].
Cai XL; Gao YH; Yu ZW; Wu ZQ; Zhou WP; Yang Y; Xu Y; Song SF; Chen SD
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):942-5. PubMed ID: 20193233
[TBL] [Abstract][Full Text] [Related]
25. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
[TBL] [Abstract][Full Text] [Related]
26. Association of XPC polymorphisms and lung cancer risk: a meta-analysis.
Jin B; Dong Y; Zhang X; Wang H; Han B
PLoS One; 2014; 9(4):e93937. PubMed ID: 24736739
[TBL] [Abstract][Full Text] [Related]
27. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y; Wang X; Zhang W; Gong S
Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
[TBL] [Abstract][Full Text] [Related]
28. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
Francisco G; Menezes PR; Eluf-Neto J; Chammas R
Eur J Hum Genet; 2008 Jun; 16(6):724-34. PubMed ID: 18285822
[TBL] [Abstract][Full Text] [Related]
29. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
Dou K; Xu Q; Han X
Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
[TBL] [Abstract][Full Text] [Related]
30. Association of XPC Gene Polymorphisms with Colorectal Cancer Risk in a Southern Chinese Population: A Case-Control Study and Meta-Analysis.
Hua RX; Zhu J; Jiang DH; Zhang SD; Zhang JB; Xue WQ; Li XZ; Zhang PF; He J; Jia WH
Genes (Basel); 2016 Sep; 7(10):. PubMed ID: 27669310
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in XPC gene and risk for prostate cancer.
Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
[TBL] [Abstract][Full Text] [Related]
32. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
33. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
Wang Y; Li Z; Liu N; Zhang G
Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
[TBL] [Abstract][Full Text] [Related]
34. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
[TBL] [Abstract][Full Text] [Related]
35. Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population.
Yue AM; Xie ZB; Zhao HF; Guo SP; Shen YH; Wang HP
Asian Pac J Cancer Prev; 2013; 14(5):3085-91. PubMed ID: 23803084
[TBL] [Abstract][Full Text] [Related]
36. XPC Lys939Gln polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians.
Ahmad Aizat AA; Siti Nurfatimah MS; Aminudin MM; Ankathil R
World J Gastroenterol; 2013 Jun; 19(23):3623-8. PubMed ID: 23801864
[TBL] [Abstract][Full Text] [Related]
37. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in XPC Gene and Risk of Uterine Leiomyoma in Reproductive Women.
Liu ZQ; Lu MY; Liu B
Pathol Oncol Res; 2020 Jul; 26(3):1459-1464. PubMed ID: 31428994
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide excision repair pathway genes and oral premalignant lesions.
Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
[TBL] [Abstract][Full Text] [Related]
40. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]